23andMe Blood Collection Study
Genetics testing company 23andMe leveraged its resources to recruit individuals for the 23andMe Blood Collection Study. The company reached out to individuals carrying the LRRK2 G2019S mutation, inviting them to donate a blood sample.
Accessing Data and Biosamples
Clinical data on the individuals in the 23andMe Blood Collection Study are available through the LCC database. To apply for access to data from the Longitudinal Study, you may submit a request here. Interested investigators must provide their intended use of the data, sign the LCC Data Use Agreement and undergo limited screening.
Investigators interested in accessing blood collected from this study are invited to email firstname.lastname@example.org to learn more about accessing these samples.
|Cohort||Clinical Data||Whole Blood||Plasma||Serum|
Have a Question?